Header Logo

Connection

MICHAEL YEN to Botulinum Toxins, Type A

Back to Details
This is a "connection" page, showing publications MICHAEL YEN has written about Botulinum Toxins, Type A.
MICHAEL YEN
Connection Strength
1.060
Botulinum Toxins, Type A
  1. Re: "Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm". Ophthalmic Plast Reconstr Surg. 2014 Jan-Feb; 30(1):76-7.
    View in: PubMed
    Score: 0.358
  2. Bupivacaine-induced myotoxicity and its effect on botulinum toxin paresis. Ann Plast Surg. 2008 Jan; 60(1):6-9.
    View in: PubMed
    Score: 0.236
  3. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids. Ophthalmic Plast Reconstr Surg. 2007 Jan-Feb; 23(1):22-4.
    View in: PubMed
    Score: 0.220
  4. Quantitative assessment of botulinum toxin injection on blink rate in blepharospasm. Orbit. 2023 Dec; 42(6):571-578.
    View in: PubMed
    Score: 0.166
  5. Botulinum toxin injection for the management of refractory filamentary keratitis. Arch Ophthalmol. 2012 Apr; 130(4):446-50.
    View in: PubMed
    Score: 0.079
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.